Huateng Pharmaceutical has a 5,000 square meter R&D building in the High-tech Development Zone of Changsha and a 34,000 square meter high standard industry park that has been completed and will be put into operation soon. Our main business includes product sales, custom synthesis, scale-up production services, and product testing and analysis services.
Huateng Pharmaceutical attaches great importance to product R&D. At present, we have more than 300 employees, among which more than 60% of employees have a master's degree or above, and 35 full-time doctors. In order to enable the company to have a full range of synthetic technologies and R&D capabilities, we have deployed high-end advanced equipment and instruments worth hundreds of millions of RMB for the R&D center.
We currently develop and produce thousands of products, including monodisperse and polydisperse PEG derivatives, high-end biochemical reagents, pharmaceutical intermediates, APIs, preparations, and targeted anti-tumor drugs. The company's R&D center is equipped with high-end analytical instruments and high-end automatic reaction equipment, such as 400M NMR, Agilent LCMS, HPLC, GC, IR, GPC, automatic polarimeter, constant moisture titrator, low-temperature reactor, high-pressure hydrogenation reaction, which can ensure high-efficiency and high-quality completion of customer orders.
Huateng Pharmaceutical has advanced R&D laboratories, pilot and scale-up production plants, and has a variety of synthetic instruments, low-temperature reactors, high-pressure hydrogenation reactors, and other reaction equipment. We can complete orders production tasks in milligrams, grams, kilograms, and even tons.
Innovation is the soul and life of Huateng. We take management innovation, technological innovation, business innovation and ideological innovation as the leading factor to realize the rapid development and value of the company.